TSVT Live signaler | Maksimer profitt med Getagraph.com

KJøP 106719 min ago

@ $5.61

Utstedt: 14 feb 2024 @ 21:45

Avkastning: -24.15%

Forrige signal: feb 14 - 19:38

Forrige signal: Selg

Avkastning: -2.09 %

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 22:00):

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States...

Stats
Dagens volum	311 142
Gjennomsnittsvolum	1.46M
Markedsverdi	218.33M
EPS	$0 ( 2024-03-05 )
Neste inntjeningsdato	( $-0.720 ) 2024-05-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.960
ATR14	$0.0110 (0.26%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Snow Jessica	Buy	62 500	Stock Options (Right to buy)
2024-04-01	Snow Jessica	Buy	31 250	Common Stock
2024-04-01	Eatwell Victoria	Buy	42 500	Common Stock
2024-04-01	Eatwell Victoria	Buy	85 000	Stock Options (Right to buy)
2024-04-01	Baird William D Iii	Buy	56 250	Common Stock

INSIDER POWER
83.01
Last 92 transactions
Buy: 4 764 989 \| Sell: 362 997

Volum Korrelasjon

Lang: 0.25 (neutral)

Kort: -0.17 (neutral)

Signal:(49.429) Neutral

2seventy bio, Inc. Korrelasjon

10 Mest positive korrelasjoner
SLDP	0.89
HOOK	0.889
OBNK	0.877
MTEM	0.872
WKHS	0.871
STRS	0.854
LCID	0.851
SBNY	0.851
RBKB	0.849
METC	0.848

10 Mest negative korrelasjoner
VOR	-0.875
ACIW	-0.862
BNIXU	-0.855
BGNE	-0.839
AQMS	-0.835
FEMB	-0.822
FCBP	-0.807
NUTX	-0.806
MICT	-0.803
ITMR	-0.801

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

2seventy bio, Inc. Korrelasjon - Valuta/Råvare

-0.16
( neutral )

-0.19
( neutral )

0.00
( neutral )

-0.37
( neutral )

0.00
( neutral )

-0.48
( neutral )

2seventy bio, Inc. Økonomi

Annual	2023
Omsetning:	$100.39M
Bruttogevinst:	$73.18M (72.90 %)
EPS:	$-4.42

FY	2023
Omsetning:	$100.39M
Bruttogevinst:	$73.18M (72.90 %)
EPS:	$-4.42

FY	2022
Omsetning:	$91.50M
Bruttogevinst:	$65.28M (71.34 %)
EPS:	$-7.13

FY	2021
Omsetning:	$54 522.00
Bruttogevinst:	$52 005.00 (95.38 %)
EPS:	$-0.0126

Financial Reports:

No articles found.

2seventy bio, Inc.

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.

Sanntidsoppdatering for 2seventy bio, Inc. [TSVT]

Upcoming Earnings Alert